Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis.
N Z Med J
; 126(1378): 60-73, 2013 Jul 12.
Article
in En
| MEDLINE
| ID: mdl-24045316
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Health Care Costs
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
N Z Med J
Year:
2013
Document type:
Article
Affiliation country:
New Zealand
Country of publication:
New Zealand